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Background: Patients in resourced-limited neonatal and pediatric intensive care units (NICU and PICU) are
vulnerable to healthcare associated infections (HAI). We report the incidence of HAI, multidrug resistant
microorganisms (MDROs) and the pattern of antibiotic usage in the first six years of a surveillance program in a
teaching hospital in Turkey.
Methods: Between 2007 and 2012 surveillance data for HAI, MDROs and antibiotic usage were collected from the
infection control department, pathology, hospital admissions and pharmacy. In 2009 hand hygiene auditing was
introduced. Hand sanitizer usage was expressed as liters per 1000 patient-days. Antibiotic usage was presented as
defined daily doses (DDD). Evidence of change in the incidence of HAI was tested using Poison regression
modeling.
Results: The rate of gram negative MDRO in PICU increased significant between 2007 and 2012 (IRR 1.5, P = 0.033)
but remained unchanged in NICU (P = 0.824). By 2012 ceftriaxone prescribing in PICU had decreased while
carbapenem prescribing increased by 80 %. In NICU carbapenem decreased by 42 % and betalactam decreased by
29 %. Hand hygiene compliance significantly improved in PICU (IRR 1.9, p < 0.001) and NICU (IRR 2.2, p < 0.001) but
compliance remained modest after three years with inconsistent levels across the 5 moments.
Conclusion: The early years of our infection control program highlights the endemicity of HAI and MDROs in our
NICU and PICU. The consistent pattern of antibiotic usage, endemic MROs in PICU and modest hand hygiene
clearly provide strategic focuses for intervention.
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Healthcare associated infections (HAI) remain a major
safety problem for vulnerable patients in pediatric and
neonatal intensive care units (ICUs) worldwide [1–3]. In
low to middle income countries where infection control
programs are resource-poor or limited, pediatric ICU
(PICU) and neonatal ICU (NICU) patients are especially
vulnerable to HAIs [1]. In high-income countries
evidence-based infection control programs have success-
fully reduced HAIs rates [4]. However, the feasibility of
successful implementation of programs outside high
resourced countries is questionable given the limited
data from low and middle income countries [2]. Turkey* Correspondence: m.mclaws@unsw.edu.au
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and in 2000 the newly formed Turkish Society of
Hospital Infection and Control developed guidelines and
introduced training for infection control nurses and
doctors. The Ministry of Health responded in 2005 by
mandating public hospitals provide routine reports on
infection control activities and in 2006 a new national
surveillance system was rolled out [6]. We report the
incidence of HAI over the first 6-years of a surveillance
program in a typical tertiary PICU and NICU in Turkey.Methods
Description of institution and infection control program
Erciyes University Hospital is a tertiary referral facility in
the Central Anatolian region of Turkey. Institutional ap-
proval was given for reporting the data. The pediatric
hospital is collocated on the adult hospital campus withdistributed under the terms of the Creative Commons Attribution 4.0
.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
ive appropriate credit to the original author(s) and the source, provide a link to
changes were made. The Creative Commons Public Domain Dedication waiver
ro/1.0/) applies to the data made available in this article, unless otherwise stated.
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annually. Surgery is rarely performed with approximately
11 pediatric or neonatal patients undergoing surgery per
year. There are 2 level-III ICUs; a 10-bed pediatric ICU
(PICU) for patients aged 1 month to 18 years and an 18-
bed neonatal ICU (NICU) with babies as small as <750 g.
Bed spacing is >1.5 m and there is 1 sink provided for
every 2-beds. PICU has 1 isolation room for every 5-beds
and in NICU there is 1 isolation room for every 9-beds.
In 2006 an organized infection control program intro-
duced a policy that one trained infection control doctor
and one certified infection control nurses (ICN) were to
be employed for each unit as a full-time equivalent
(FTE) staff. Since 2006, all patients admitted to ICU
have been routinely screened for vancomycin resistant
enterococci and carbapenem resistant Enterobacteria-
ceae. Surveillance definitions were applied in accord-
ance with the Centers for Disease and Control (CDC)
[4]. From 2009 a multimodal hand hygiene education
promotion campaigns was introduced that included al-
cohol based hand rub (ABHR) at every bedside, chlor-
hexidine containing soap and hand hygiene compliance
audits with feedback. Trained ICNs audit healthcare
workers’ (HCWs) compliance with My Five Moments
using the World Health Organization audit tool and
audit in accordance with the guidelines [7]. Monthly
and quarterly HAI and hand hygiene results are re-
ported to the infection control committee.
Data collection
Between 2007–2012 surveillance for HAI included active
surveillance by the ICN who also validated all laboratory
HAI notifications. Surveillance data are collected rou-
tinely as a quality and safety activity of the Hospital.
These data were collected from the infection control
department as well as device utilization and device-
associated infection rates for central line associated
bacteremia (CLABSI), catheter associated urinary tract
infections (CAUTI), incidence of multidrug resistant mi-
croorganisms (MDRO) and hand hygiene compliance.
Hospital admissions provided the number of patient
days, occupancy rate per year, length of stay and the 24-h
nurse-to-patient ratio. The nursing workload was mea-
sured by the 24-h nurse-to-patient ratio divided by the
total number of nurses during the 24-h period using the
patients’ census for the day. Consumption of alcohol
based hand rub (ABHR) was provided by pharmacy and
expressed as liters per 1000 patient-days. Pharmacy pro-
vided antimicrobial use (reported as defined daily dose
[DDD] and is the average maintenance dose per day for
each drug) normalized per 1000 patient-days in accord-
ance with World Health Organization (WHO Collabor-
ating Centre for Drug Statistics Methodology, 2012).
The most widely used antibiotics examined for usagewere: ceftriaxone, beta-lactam/beta-lactamase inhibitors,
carbapenem, aminoglycoside, glycopeptide, linezolid,
metronidazole, quinolones, colistin, tigecycline, flucona-
zole. A microorganism was defined as MDRO if it pro-
vided resistant to more than three classes of antibiotics;
aminoglycosides, antipseudomonal penicillins, carbapen-
ems, cephalosporins, beta-lactam/beta-lactamase inhibitor,
quinolones, colistin, tigecycline [7]. The most prevalent
MDRO included Acinetobacter baumannii, Pseudomonas
aeruginosa, extended spectrum beta-lactamase (ESBL)
Klebsiella pneumoniae and ESBL Esherichia coli, methicil-
lin resistant Staphylococcus aureus (MRSA) and ampicillin
resistant Enterococcus. Pathogens were identified using
Vitek-2 automated method and interpreted according to
Clinical Laboratory Standards Institute Guidelines: CLSI.
Mean inhibitory concentrations were performed using a
standard method for antimicrobial susceptibility testing in
accordance with Twenty-fourth informational supplement
M100-S18 (Villanova, PA, USA, 2008).
Analysis
The difference in the mean length of stay, with ± one
standard deviation (SD), was calculated using ANOVA.
Frequencies and 95 % CIs were established separately for
hand hygiene compliance in PICU and NICU from 2009
to 2012. Total HAI rates expressed per 1000 patient-
days and VAP, CLABSI and CAUTI were expressed per
1000 device-days, with 95 % CIs for 2007 to 2012. Exact
binomial method around a proportion was used to test
for change in incidence. All three specific HAIs were ag-
gregated to examine whether small number of infections
in each of the three types prevented detection in the
change in rates. On examination of the precision of the
estimates, using 95 % CIs, precision was not warranted
to one decimal place and all decimals were rounded up
at 0.6 and only rates <1 were present to one decimal
point. Changes in the percentage point difference in
hand hygiene rates from 2009 to 2012 were calculated.
The effect of the introduction of the My five moments
for hand hygiene campaign on total compliance for each
of the five hand hygiene indications and HAI was esti-
mated using incidence rate ratio (IRR) produced from a
Poisson generalized linear model (GLM) which was
chosen because total HAI had a Poisson distribution.
IRR could not be established where rates were zero. The
first year of observation was used as the baseline for
measuring change in IRRs over the following years. HAI
were statistically rare events resulting in the inability for
the effect of hand hygiene on specific HAIs to be mod-
eled using either GLM or negative binomial regression.
Hand hygiene compliance rates were also reported for
the magnitude of change described in percentage points
(PP). Alpha was set at the 5 % level. All analysis was
undertaken using SPSS version 21 (IBM, Armonk, NY).
Table 1 Healthcare associated infections for Neonatal and
Pediatric ICUs between 2007 and 2012
Year Neonatal ICU Pediatric ICU
2012 19 [16–23] (108/5681) 25 [20–31] (88/3460)
IRR = 0.93, 0.957 IRR = 0.65, 0.002
2011 18 [14–21] (86/4792) 24 [19–29] (83/3516)
IRR = 0.87, 0.925 IRR = 0.60, <0.001
2010 23 [19–28] (106/4522) 24 [19–30] (83/3457)
IRR = 1.10, 0.925 IRR = 0.61, 0.001
2009 20 [16–24] (84/4238) 32 [26–38] (109/3411)
IRR = 0.97, 0.980 IRR = 0.81, 0.117
2008 22 [17–27] (87/3994) 38 [31–45] (116/3050)
IRR = 1.1, 0.967 IRR = 0.97, 0.804
2007 20 [17–25] (91/4434) 39 [33–47] (122/3106)
IRR = 1 (reference year) IRR = 1 (reference year)
Rate/1000 patient-days [95 % CI] (HAI/patient-days), Incidence rate ratio
(IRR), P-value
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Patient acuity
The average number of patient-days for 2007–2012 in
NICU was 4,610 (range 3,994 to 5,681). In PICU the
average number of patient-days for 2007–2012 was
3,333 (range 3,050 to 3,516). The mean length of stay in
NICU was 30.2 days (SD ± 11.1) in 2007 and increased
to 38.5 days (SD ± 14.2) by 2012 (P < 0.0001). The mean
length of stay in PICU was 28.3 days (SD ± 19.0) in 2007
and increased to 29.3 (SD ± 13.3) by 2012 (P < 0.0001).
In 2007 the ratio of nurse-to-patient admissions in
NICU was 0.9:1 and steadily increased to reach 1.3:1 by
2012. In PICU the ratio of nurse-to-patient admissions
remained at 1:1 with the exception of 2008 and 2009
when the ratio increased to 1.3:1 and 1.6:1 respectively
before returning to 1:1 thereafter.
Specific healthcare associated infections
The rate of CAUTI in NICU remained stable between
2007 (9 per 1000 catheter-days, 95 % CI 0.2–52) and
2012 (4 per 1000 catheter-days, 95 % CI 0.1–22) (IRR
0.43, P = 0.670). In PICU the CAUTI rate remained
stable between 2007 (8 per 1000 catheter-days, 95 % CI
3–15) and 2012 (9 per 1000 catheter-day, 95 % CI 5–15)
(IRR 1.3, P = 0.622).
The CLABSI rate in NICU did not change significantly
(P = 1.0) between 2007 (0 per 1000 line-days, 95 % CI 0–4)
and 2012 (0 per 1000 line-days, 95 % CI 0–11). In PICU
the CLABSI rate remained stable between 2007 (6 per
1000 catheter-days, 95 % CI 3–13) and 2012 (8 per 1000
catheter-days, 95 % CI 5–13) (IRR 1.2, P = 0.615).
The rate of VAP in NICU remained unchanged be-
tween 2007 and 2012 ranging from 10 (95 % CI 7–14)
per 1000 device-days in 2007 to 7 (95 % CI 4–10) per
1000 device-days (IRR 0.71, P = 0.814). In PICU the VAP
rate remained unchanged from 9 (95 % CI 6–14) per
1000 device-days in 2007 to 11 (95 % CI 8–16) per 1000
device-days in 2012 (IRR 1.2, P = 0.412).
Total healthcare associated infections
The rate of aggregated HAIs in NICU remained stable
over the first six years of surveillance with the rate at 20
per 1000 patient-days in 2007 and 19 per 1000 patient-
days in 2012 (IRR 0.93, P = 0.957) (Table 1). The total
HAI rate in PICU in 2007 was 39 per 1000 patient-days
and declined significantly in 2010 (IRR 0.61, P < 0.001)
and in 2012 (IRR 0.65, P = 0.002) (Table 1).
Multiple drug resistant microorganisms
The rate of MDROs in NICU remained unchanged for
A. baumanni starting at 2.26 per 1000 patient-days in
2007 and remained steady at 2.82 per 1000 patient-days
in 2012 (IRR 0.8, 95 % CI IRR 0.4–2, P = 0.58), K.pneu-
monia at 1.13 and 0.7 per 1000 patient-days in 2007 and2012 respectively (IRR 0.6, 95%CI IRR 0.2–2.5, P = 0.483)
and P.aeroginosa at 1.58 and 0.7 per 1000 patient-days
in 2007 and 2012 respectively (IRR 0.4, 95%CI IRR 0.1–1.4,
P = 0.198). When all GNB were aggregated the rate in
NICU from 2007 and 2012 (IRR 0.9, 95%CI IRR 0.5–2,
P = 0.824).
The rates in PICU remained unchanged for A. bau-
manni starting at 7.41 per 1000 patient-days in 2007 and
remained steady at 5.49 per 1000 patient-days in 2012
(IRR 0.74, 95 % CI IRR 0.5–1.4, P = 0.335) and K.pneu-
monia also remained steady at 3.54 and 1.73 per 1000
patient-days between 2007 and 2012 respectively (IRR
0.5, 95 % CI IRR 0.2–1.4, P = 0.159). P.aeroginosa de-
creased from 5.15 per 1000 patient-days in 2007 to 2.02
per 1000 patient-days by 2012 (IRR 0.4, 95 % CI IRR
0.2–1 P = 0.039). When all GNB MRDOs were aggre-
gated the rate in PICU significantly decreased from 18.3
per 1000 patient-days in 2007 to 11.8 per 1000 patient-
days by 2012 (IRR 0.7, 95 % CI IRR 0.5–1, P = 0.033).
The MRSA rate in NICU in 2007 was 0 per 1000
patient-days and remained stable with the exception of
2008 when 2 patients acquired MRSA infection (0.5 per
1000 patient-days, P = 1.0). The MRSA rate in PICU in
2007 was 2 per 1000 patient-days and dropped signifi-
cantly to 0 per 1000 patient-days in 2012 (P < 0.05).
Antimicrobial daily dose usage
In NICU betalactam antibiotics (range 87 to 146 g) were
more commonly prescribed while carbapenems, amino-
glycosides and glycopeptides were prescribed less fre-
quently (Fig. 1).
By 2012 betalactam prescribing had decreased by 29 %
(122 g to 87 g) and carbapenem consumption decreased

































Fig. 1 Antibiotic gram usage in Neonatal and Pediatric ICUs
between 2007-2012
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one while aminoglycoside and glycopeptides were less
common. In PICU by 2012, ceftriaxone usage had fallen
14 % (207 g in 2007 to 178 g in 2012). Increases in usage
in PICU were marked by an 80 % increase in carba-
penem usage (152 g in 2007 to 273 g in 2012) and 44 %
increase in betalactam usage (183 g in 2007 to 329 g
in 2012). PICU and NICU infrequently prescribed
metronidazole, quinolone, colistin, linezolid, tigecycline
and fluconazole.
Hand hygiene by moments
Total compliance in hand hygiene significantly improved
in both ICUs after the introduction in 2009 of the hand
hygiene program (Tables 2 and 3). Compliance with mo-
ment 5, after touching the patient surroundings, did not
improved in either NICU or PICU. By 2012 compliance
in the NICU increased significantly for moment 1 (IRR
1.5, 65.6 %, p = 0.001), moment 2 (IRR 2.0, 79 %, p = 0.001)
and moment 4 (IRR 1.4, 76 %, p = 0.006) (Table 2). By 2012
compliance in PICU increased significantly for moment
1 (IRR 2.4, 50 %, p < 0.001), moment 2 (IRR 4.6, 48 %,
p < 0.001) and moment 4 (IRR 1.5, 67 %, p = 0.008)
(Table 3). NICU had higher compliance than PICIU for
moment 1 by 15 percentage points (PP) in 2012, 31PP
higher for moment 2 and 9PP higher for moment 4.Total compliance in 2012 in NICU was 9PP higher
than PICU and this was reflected in the ABHR usage in
NICU that was three times higher than in PICU (Fig. 2).
Discussion
Intrinsic risk factors, such as an immature immune sys-
tem and severity of illness, and extrinsic factors, such as
poor health services infrastructure, invasive devices and
the medication associated with these devices, increase
the risk of HAI acquisition in patients admitted to NICU
and PICU [3, 8]. In low to middle income countries fac-
tors associated with the persistence of HAI in NICU and
PICU are unlike those in high income countries, such as
a lack of crucial elements of an infection control pro-
gram, a legal framework for establishing and enforcing
infection control programs and finances [2]. Other risk
factors unique to low and middle income healthcare set-
tings is overcrowded wards, poor nurse-to-patient ratio,
patient malnutrition and severity of illness [2]. Since
2006 some of the essential components of the infection
control programs in our ICUs are similar to high
resourced countries and includes the development of in-
fection control procedures, surveillance, education and
monthly feedback to ICU staff on their HAI prevention
performance. Yet, despite comparable device utilization
rates to those reported in the USA the device-associated
HAIs in both our ICUs were 2–20 times higher than the
rates in USA [9]. Rosenthal et al. also reported a higher
incidence of VAP in academic hospitals in low to middle
income countries [3]. Smulders et al. demonstrated that
infection prevention bundles are effective in neonatal
and pediatric patients rate of CLABSI and VAP [10].
Yet, our intractable CAUTI, CLABSI and VAP rates re-
main unexplained and may be due to a lack of institu-
tionalized compliance by our PICU or NICU with each
of the bundle items. The drop in HAI is most likely in
response to the aggregation of statistically rare events
and not a result of infection prevention. Similarly, our
inability to identify a significant change in MDROs in
PICU except when we aggregated all GNB suggests that
the sample size is possibly a factor. Our academic hos-
pital receives patients transferred with severe illness. Im-
portant intrinsic factors contributing to HAI were not
evaluated and compliance with prophylaxis was also not
evaluated. However, poor antibiotic prescribing and poor
hand hygiene compliance may be two important causal
contributors.
Antibiotics are the most frequently used medicines in
neonatal and pediatric ICUs. Only consumption in
grams was measured so judgment of antibiotic over-
prescribing in our tertiary referral hospital with admis-
sions and transfers of patients with severe disease can
only be suggested from the trends in consumption.
Although we expect antibiotics are commenced
Table 2 Neonatal ICU Hand hygiene compliance by Moments between 2009 and 2012
Year Five Moments % complied [95 % CI] (Observed/Total opportunities) Incidence Rate Ratio (IRR), P-value
Moment 1 Before patient contact Moment 2 Before a procedure Moment 3 After procedure/risk
of exposure to body fluid
Moment 4 After patient contact Moment 5 After contact
with patient environment
Total Moments
2012 65.6 [60.6–70.2] (259/395)
IRR = 1.5, 0.001
78.7 [68.7–86.6] (70/89)
IRR = 2.0, 0.001
14.9 [9.4–22.1] (20/134)
IRR = 1.5, 0.338
76.4 [71.7–80.6] (281/368)
IRR = 1.4, 0.006
33.4 [27.9–39.3] (93/278)
IRR = 0.67, 0.782
57.2 [54.4–59.9 %] (723/1264)
IRR = 2.2, <0.001
2011 62.5 [58.1–66.7] (318/509)
IRR = 1.4, 0.004
59.4 [51.1–67.4] (88/148)
IRR = 1.5, 0.046
25.8 [18.4–34.4] (32/124)
IRR = 2.6, 0.016
65.2 [60.5–69.7] (281/431)
IRR = 1.3, 0.018
55.7 [47.8–63.4] (93/167)
IRR = 0.59, 0.731
58.1 [55.4–60.7] (801/1379)
IRR = 2.9, <0.001
2010 57.0 [53.3–60.7] (414/726)
IRR = 1.3, 0.031
56.3 [50.6–61.9] (174/309)
IRR = 1.4, 0.062
17.4 [12.8–22.9] (41/235)
IRR = 1.7, 0.150
68.8 [65.4–72.1] (525/763)
IRR = 1.2, 0.050
37.7 [30.3–45.5] (63/167)
IRR = 1 (reference year)
56.3 [54.2–58.4] (1217/2160)
IRR = 4.7, <0.001
2009 44.6 [37.8–51.5] (95/213)
IRR = 1 (reference year)
39.0 [28.0–50.7] (30/77)
IRR = 1 (reference year)
10.0 [4.4–18.8] (8/80)
IRR = 1 (reference year)
56.1 [48.8–63.1] (111/198)
IRR = 1 (reference year)
- 43.0 [38.8–47.1] (244/568)














Table 3 Pediatric ICU Hand hygiene compliance by Moments between 2009 and 2012
Year Five Moments % complied [95%CI] (Observed/Total opportunities) Incidence Rate Ratio (IRR), P-value
Moment 1 Before patient
contact
Moment 2 Before a procedure Moment 3 After procedure/risk
of exposure to body fluid
Moment 4 After patient contact Moment 5 After contact
with patient environment
Total Moments
2012 50 [45–55] (231/461)
IRR = 2.4, <0.001
48 [40–55] (88/185)
IRR = 4.6, <0.001
28 [23–33] (97/345)
IRR = 4.2, 0.001
67.5 [63–71] (353/523)
IRR = 1.5, 0.008
43 [39–47] (251/585)
IRR = 1.6, 0.749
49 [46–51] (1020/2099)
IRR = 1.9, <0.001
2011 46 [41–52] (179/385)
IRR = 2.2, 0.001
52 [45–58] (124/239)
IRR = 5.0, <0.001
39 [34–45] (120/304)
IRR = 5.9, <0.001
74 [69.9–78.3] (324/436)
IRR = 1.7, 0.001
48 [42–54] (139/291)
IRR = 1.4, 0.807
53 [51–56] (886/1655)
IRR = 2.4, <0.001
2010 43 [39–47] (315/733)
IRR = 2.0, 0.002
46 [42–51] (217/469)
IRR = 4.5, <0.001
24 [21–28] (132/541)
IRR = 3.7, 0.002
67 [63–71] (467/696)
IRR = 1.5, 0.008
43 [42–50] (251/544)
IRR = 1 (reference year)
43 [42–45] (1296/2983)
IRR = 2.1, <0.001
2009 21 [14–31] (21/99)
IRR = 1 (reference year)
10 [4–20] (7/68)
IRR = 1 (reference year)
7 [2–14] (6/90)
IRR = 1 (reference year)
45 [35–55] (48/107)
IRR = 1 (reference year)
- 22 [18–27] (82/364)



























Fig. 2 Liter usage of Alcohol Based Hand Rub (ABHR) and Chlorhexidine (CGH) containing soap in Neonatal and Pediatric ICUs between 2008-2012
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scribed antibiotics in NICU appeared to have declined.
The carbapenem resistant A.baumannii in PICU was en-
demic between 2009 and 2012 and unlike carbapenem
usage globally [11] there was a conspicuous increase,
80 %, in carbapenem prescribing during this period. In
NICU, staff carbapenem prescribing patterns decreased
by 42 % over the same period and may have been in re-
sponse to a peak in carbapenem resistant A.baumannii
in 2011. Colistin prescribing is rare in our ICUs unlike
elsewhere [11]. The persistence of GNB MDROs, specif-
ically A.baumannii, K.pneumonia and P. aeroginosa, and
our patterns of repeated and prolonged prescribing need
to be challenged to urgently address habitually poor pre-
scribing practices by our ICU physicians [12–14]. Even
in the absence of decolonization practices, such as chlor-
hexidine body wash [15], a modest improvement in our
hand hygiene rates has kept the transmission of MRSA
infections low [16]. We did not evaluate the association
between antibiotic use and resistance patterns or reduc-
tion in infection due to change in antibiotic prescribing.
The introduction of a hand hygiene program in 2009
resulted in a 15PP improvement in total compliance by
NICU staff and a 27PP improvement by PICU staff.
Compliance with moment 1, moment 2 and moment 4
improved 21PP, 40PP and 20PP respectively in NICU
while poor compliance for moments 3 and 5 reduced
the overall compliance rate. PICU staff performed mo-
ments 2, 3 and 5 poorly while the improvements in Mo-
ments 1 and 4 by 29PP and 22PP respectively suggests a
modest change in behavior. Glove use for moments 2
and 3 may explain our failure to achieve important be-
havioral change. However, even with the availability of
ABHR and monthly compliance feedback to staff the
final compliance in both ICUs was still low. The method
of direct observation for monitoring hand hygiene com-
pliance usually results in some degree of HawthorneEffect, therefore the usual compliance rates may in fact
be lower than the rate we are reporting.
In Turkey, national infection control programs com-
menced nearly 50 years after other European countries.
Despite our late start and limited resources, we have dem-
onstrated that our surveillance activities have continued.
Countries with limited resources have constraints in com-
mon such as, hospital infrastructure, overcrowding, un-
derstaffing, poor infection control program funding and
adherence to guidelines. The barriers to further progres-
sion includes the continued high workload demonstrated
by our very low nurse-to-patient ratio ranging 0.6:1 to
0.9:1 in PICU and 0.5:1 to 0.6:1 in NICU. High patient
loads may be an important barrier to hand hygiene prac-
tice [17]. Low nurse-to-patient ratio significantly increases
the risk for HAI with a much as 30 % of HAI possibly
being avoided when nurse-to-patient ratio is maintained
at >2.2 nurses to one patient [18]. Two contributing fac-
tors to the endemic HAI rates and poor hand hygiene
compliance in our ICUs may include nursing staff car-
ing for >1 patient during night shifts and the prolonged
night shift, routinely 16-h. These two factors have been
found to adversely impact a clinician’s ability to perform
at their very best [18, 19]. Innovative behavior change
programs [20] may have a more immediate benefit on
HAI rates given we may not be able to remedy the
nurse-to-patient ratio in the near future. Acinetobacter
species readily acquire resistance due to, in part, its excel-
lent biofilm-producing ability that enables it to survive in
hospital environments [21]. Any breakdown in environ-
mental cleaning will contribute to a persistent endemicity,
such as we have witnessed.
Our study provides an insight into the early phase of
infection control programs in a middle-income country
although we acknowledge that there are limitations to
interpretations of our study that includes the collection
of certain data retrospectively, absence of reasons for
Alp et al. Antimicrobial Resistance and Infection Control  (2015) 4:34 Page 8 of 8prescribing and patient demographic characteristics.
Given any improvements in infrastructure will be slow
to occur, a middle-income healthcare system such as ours
needs to look towards a more effective use of existing
resources, effecting governmental prioritization of HAI
prevention programs and urgent changes to antibiotic
prescribing practices.
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